Armistice Capital, LLC Argenx Se Transaction History

Armistice Capital, LLC

$7.69 Billion
Q2 2024

A detailed history of Armistice Capital, LLC transactions in Argenx Se stock. As of the latest transaction made, Armistice Capital, LLC holds 200,000 shares of ARGX stock, worth $107 Million. This represents 1.12% of its overall portfolio holdings.

Number of Shares

200,000

Previous 264,000 24.24%

Holding current value

$107 Million

Previous $104 Million 17.25%

% of portfolio

1.12%

Previous 1.42%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$356.01 - $451.55 $22.8 Million - $28.9 Million	-64,000 Reduced 24.24%	200,000 $86 Million
Q1 2024 May 15, 2024	SELL	$356.95 - $413.29 $19.3 Million - $22.3 Million	-54,000 Reduced 16.98%	264,000 $104 Million
Q4 2023 Feb 13, 2024	BUY	$338.91 - $506.01 $40 Million - $59.7 Million	118,000 Added 59.0%	318,000 $121 Million
Q2 2023 Aug 14, 2023	SELL	$360.14 - $422.58 $8.64 Million - $10.1 Million	-24,000 Reduced 10.71%	200,000 $77.9 Million
Q1 2023 May 15, 2023	BUY	$334.23 - $403.65 $18 Million - $21.8 Million	54,000 Added 31.76%	224,000 $83.5 Million
Q4 2022 Feb 14, 2023	BUY	$342.17 - $402.31 $17.1 Million - $20.1 Million	50,000 Added 41.67%	170,000 $64.4 Million
Q3 2022 Nov 14, 2022	SELL	$343.2 - $395.75 $23.3 Million - $26.9 Million	-68,000 Reduced 36.17%	120,000 $42.4 Million
Q2 2022 Aug 15, 2022	SELL	$269.58 - $378.88 $3.23 Million - $4.55 Million	-12,000 Reduced 6.0%	188,000 $71.2 Million
Q1 2022 May 16, 2022	BUY	$254.45 - $351.06 $3.05 Million - $4.21 Million	12,000 Added 6.38%	200,000 $63.1 Million
Q4 2021 Feb 14, 2022	SELL	$272.01 - $353.03 $5.44 Million - $7.06 Million	-20,000 Reduced 9.62%	188,000 $65.8 Million
Q3 2021 Nov 15, 2021	BUY	$295.0 - $350.58 $8.85 Million - $10.5 Million	30,000 Added 16.85%	208,000 $62.8 Million
Q2 2021 Aug 16, 2021	BUY	$257.11 - $319.92 $7.2 Million - $8.96 Million	28,000 Added 18.67%	178,000 $53.6 Million
Q1 2021 May 17, 2021	BUY	$268.3 - $380.31 $18.8 Million - $26.6 Million	70,000 Added 87.5%	150,000 $41.3 Million
Q4 2020 Feb 16, 2021	SELL	$248.13 - $308.36 $1.24 Million - $1.54 Million	-5,000 Reduced 5.88%	80,000 $23.5 Million
Q3 2020 Nov 16, 2020	BUY	$215.51 - $272.51 $3.66 Million - $4.63 Million	17,000 Added 25.0%	85,000 $22.3 Million
Q2 2020 Aug 14, 2020	BUY	$127.44 - $232.72 $8.67 Million - $15.8 Million	68,000 New	68,000 $15.3 Million

Others Institutions Holding ARGX

# of Institutions

371

Shares Held

31.4M

Call Options Held

303K

Put Options Held

429K

View Full List

About ARGENX SE

Ticker ARGX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,323,800
Market Cap $29.7B
Description
argenx SE, a biotechnology company, focuses on developing various therapies for the treatment of autoimmune diseases in the United States, the Netherlands, Belgium, Japan, Switzerland, Germany and France. Its lead product candidate is efgartigimod for the treatment of patients with myasthenia gravis, immune thrombocytopenia, pemphigus vulgaris, ...

More about ARGX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Armistice Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Armistice Capital, LLC with notifications on news.

Account

Armistice Capital, LLC Argenx Se Transaction History